Zifo RnD Solutions Joins The Flaskdata Partner Program

Flaskdata.io, based in Modin, Israel, is pleased to announce their partnership with Zifo RnD Solutions as part of the Flaskdata Partner Program. Together the two companies will leverage their solutions to help Pharma, Biotech, Manufacturing QC, Medical Devices, Specialty Chemicals and other research-based organizations accelerate their study and development.

A spokesperson for Flaskdata says, “Zifo RnD Solutions is an amazing implementation partner. They have taking an invaluable part in helping us deliver 20 clinical trial implementations on the Flaskdata.io platform for collecting real-time interpretable data for clinical trials. Zifo is a natural fit to partner with us, with seven of the ten top Biopharma companies already using their solutions. Together we can help more organizations accelerate their programs, minimizing delays and enabling them to reduce quality issues by providing real-time monitoring.”

The Flaskdata partner program is currently open to Customer Development partners, CRO partners, Embedded API partners and Design partners. Their spokesperson continues, “If your company wants to work with a tech company that thinks differently about managing clinical trials, we think you should speak with us. We have the experience of working globally in clinical research, manufacturing, sales and marketing. We have used our model to innovate locally and work globally to help our partners get their solutions to the organizations that need them the most.”

Recently, USA Today, Street Insider, Digital Journal and several other global news sites featured articles on Flaskdata’s Automation Technology, which is aiding those who wish to develop coronavirus vaccines. The news highlighted the fact that the company’s technology supports the automatic detection of issues in clinical trials for the development of treatment or vaccines for any pandemic virus. FlaskData’s innovative and patent-pending cloud technology provides real-time detection and improvement of patient compliance to treatment.

Their company spokesperson states, “I’m sure that I want to go real fast when it comes to the clinical trials needed for the development of treatments and vaccines for a pandemic virus. The faster a treatment or vaccine is developed, the more lives can be saved. This is what the FlaskData automation technology can help with.” Their Flask API provides a secure mobile/device API service which facilitates the collection of data from mobile data devices on-site or elsewhere as well as other medical devices at home or worn by the subject (which are connected to their monitoring system).

Scaling to meet the demands of a global mass trial does not strain the FlaskData Digital system either, as it can ingest data at a rate of 100,000 events per second from any or all data sources. Coupled with the FlaskData Detect & Respond component that takes care of patient compliance automation, the continuous data feed offers a real-time picture of the result as well as the real-time picture for protocol compliance in patient-centric research.

The company envisages real-time data streaming for all clinical trials post COVID-19. With a pathogen like COVID-19, or the next pandemic like it, companies that work in the life sciences cannot afford delays in batch processing, where latency requires that they take six to twelve months to receive results. Currently, many clinical trials are monitored by hand, which is a very slow, very expensive way to collect information. It can also mean that quality standards are compromised. With a pathogen like COVID-19 and the urgency of research pertaining to its control and eradication, it is vital that quality is maintained throughout any research or development project. Through Flaskdata’s automated real-time alerts, clinical operations teams can focus their efforts on meeting patient intake requirements as well as their patient compliance goals.

Flaskdata’s spokesperson concludes, “We know that there are huge issues with onsite visits and study monitors. Our mobile data collection for patients and investigators, coupled with our automated protocol compliance monitoring and AI-driven detection and response systems, can generate clinically-interpretable data weeks faster than with onsite-visits and paper source verification. Our partner program is open to those who, like Zifo, want to collaborate to develop their business."

Those interested in FlaskData’s innovative technology and their Partner Program can visit their official website and get in contact for more information. More resources regarding their big-data tools, their products and their team can be explored on their website as well.